Fenwick represented Marshall Wace, a global alternative asset manager, in the intellectual property due diligence aspect of its Series B investment in Elektrofi, a Boston-based biotechnology company focused on drug formulation and delivery innovations. Marshall Wace and BVF Partners led the financing with participation from Janus Henderson and Logos Capital.
A portion of the funding will be used to establish a centralized GMP manufacturing line in support of multiple upcoming clinical trials. Elektrofi will also plan to double their headcount over the next 12-18 months to accelerate development across a growing pipeline of licensed programs with leading pharma and biotech. More information about Elektrofi’s $40 million Series B financing can be obtained from their press release.
The Fenwick transaction team was led by intellectual property partners Daniel Becker and Carl Morales.